|
Volumn 9, Issue 7, 2004, Pages 11-15
|
Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MENINGOCOCCUS VACCINE;
SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHILD;
EPIDEMIC MENINGITIS;
FEMALE;
HEALTH SURVEY;
HUMAN;
INCIDENCE;
INFANT;
MALE;
MASS IMMUNIZATION;
METHODOLOGY;
MIDDLE AGED;
NEWBORN;
OUTCOME ASSESSMENT;
PRESCHOOL CHILD;
RISK ASSESSMENT;
RISK FACTOR;
SEASON;
SPAIN;
STATISTICS;
TREATMENT OUTCOME;
VACCINATION;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
INCIDENCE;
INFANT;
INFANT, NEWBORN;
MALE;
MASS IMMUNIZATION;
MENINGITIS, MENINGOCOCCAL;
MENINGOCOCCAL VACCINES;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
POPULATION SURVEILLANCE;
RISK ASSESSMENT;
RISK FACTORS;
SEASONS;
SPAIN;
TREATMENT OUTCOME;
VACCINATION;
MLCS;
MLOWN;
|
EID: 33645239697
PISSN: None
EISSN: 15607917
Source Type: Journal
DOI: 10.2807/esm.09.07.00474-en Document Type: Article |
Times cited : (58)
|
References (0)
|